Detection of Aminoglycoside and Macrolide Resistance Mechanisms in Methicillin-Resistant Staphylococcus Aureus. 2016

Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu

Methicillin-resistant Staphylococcus aureus can become resistant to many different classes of antibiotics. Objective: To characterize aminoglycoside and macrolide resistance mechanisms in MRSA strains in relation to antibiotic susceptibility patterns. Materials and methods: We tested 86 MRSA strains using multiplex PCR for detection of genes mecA, aac(6′)-Ie/aph(2″), ant(4′)-Ia, aph(3′)-IIIa, ermA, ermC and msrA. Results: There was a prevalence of msrA (32.5%), ermC (30.2%) and aph(3')-IIIa (61.6%) genes, which are less frequently reported in MRSA. Most msrA genes was detected in PVL positive strains (92.8%) and was associated only with non-MDR strains, while ermC genes were associated with MDR strains. PVL producing strains were characterized by the presence of aph(3′)-IIIa (93.1%) and msrA genes (93.1%), being phenotypically susceptible to clindamycin. Conclusions: Detection of aminoglycoside and macrolide resistance genes allowed us to establish the concordance between genotypic and phenotypic methods and to correlate the presence of certain resistance genes with the type of circulating strain and the production of virulence factors.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012383 Romania A country in southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine. The capital is Bucharest. Rumania,Roumania
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
August 1988, The Journal of hospital infection,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
April 2013, Mikrobiyoloji bulteni,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
January 2006, Microbial drug resistance (Larchmont, N.Y.),
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
May 1988, The Japanese journal of antibiotics,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
June 2008, Current microbiology,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
April 2006, The Journal of hospital infection,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
March 1991, The Journal of infectious diseases,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
May 2008, Vojnosanitetski pregled,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
February 2001, Postgraduate medicine,
Olilvia Simona Dorneanu, and Cătălina Luncă, and E V Năstase, and Cristina Gabriela Tuchiluş, and Teodora Vremeră, and Luminiţa Smaranda Iancu
November 1992, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!